Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of DPP4 Inhibition on Growth Hormone Secretion

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Jessica Koch Devin, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01701973
First received: October 3, 2012
Last updated: October 31, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)